RSC Advances · 2018 · 24 citations · 60 references
Natural SciencesChemistryPharmacologyBiomaterialsDrug DiscoveryNanomaterialsAlzheimer DiseaseAmyloid FormationNanomedicineNanotoxicologyNeurodegenerative Disease PharmacotherapyAggregation InhibitorsAmyloid Beta AggregationAmyloid Beta PlaquesAmyloid InhibitionAmyloid PlaquesFullerenesLow SolubilitySolubility
peptide. These data suggest that fullerenemalonates require specific substituents designed as sodium salt molecules to inhibit Aβ fibrillization and perform with low toxicity. These are promising molecules for developing future therapies involving Aβ aggregates in diseases such as AD and other types of dementia.
60
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text